Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
Food and ‌Drug Administration on Monday ⁠declined ‌to approve ‍Atara Biotherapeutics' cell therapy ​for ‌a rare form of blood ...
FOLLOWING the identification of a potential safety and quality concern, the Food and Drug Administration (FDA) on Monday ...
New options for testing and treating some of the most common sexually transmitted diseases are becoming available.
A cheese recall impacting 20 states was issued after certain products tested positive for listeria, according to the Food and ...
The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.
Food and Drug Administration commissioner Marty Makary's flagship effort to overhaul how the agency reviews drugs is facing ...
The FDA announced that a recall of cheese products has been upgraded to the most serious risk category after testing positive ...
The Food and Drug Administration has upgraded a recall to the highest danger level after several cheese products tested positive for listeria.Specific cheese<a class="excerpt-read-more" href=" More ...
Company demonstrates commercial-scale production of its Toll-like Receptor 5 (TLR5) agonist for Acute Radiation Syndrome (ARS) and Neutropenia through wholly owned contract development manufacturing ...
The products were recalled in 26 states because they may contain plastic fragments, which are a safety hazard. The FDA has given the recall the second-highest risk level.
The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...